QT
KROS icon

Quantbot Technologies’s Keros Therapeutics KROS Stock Holding History

Quantbot Technologies’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$20 – 1954
2025
Q4 		$20 Sell
1
-385
-100% -$6.75K ﹤0.01% 1653
2025
Q3 		$6.11K Hold
386
– – ﹤0.01% 1643
2025
Q2 		$5.15K Hold
386
– – ﹤0.01% 1562
2025
Q1 		$3.93K Buy
386
+6
+2% +$70 ﹤0.01% 1396
2024
Q4 		$6.01K Buy
+380
New +$19.7K ﹤0.01% 1391
2022
Q3 		– Sell
-6,364
Closed -$175K – 1847
2022
Q2 		$175K Buy
+6,364
New +$279K 0.02% 970
2022
Q1 		– Sell
-200
Closed -$11K – 1859
2021
Q4 		$11K Buy
+200
New +$9.97K ﹤0.01% 1303

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return